Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China.
| Last: | $0.82 |
|---|---|
| Change Percent: | 3.8% |
| Open: | $0.7899 |
| Close: | $0.79 |
| High: | $0.85 |
| Low: | $0.7899 |
| Volume: | 53,588 |
| Last Trade Date Time: | 09/19/2025 01:18:10 pm |
| Market Cap: | $1,088,253,271 |
|---|---|
| Float: | 10,014,684 |
| Insiders Ownership: | N/A |
| Institutions: | 2 |
| Short Percent: | 17978% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.investors.lakeshorebio.com |
| Country: | CN |
| City: | Beijing |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about LakeShore Biopharma Co. Ltd (NASDAQ: LSB).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
